Allogenic human umbilical cord derived mesenchymal stem cell (Saipu Biotech)

人脐带间充质干细胞（赛浦生物科技）

Report date: 2026/05/26 15:54:14

Base Information

Drug NameAllogenic human umbilical cord derived mesenchymal stem cell (Saipu Biotech)
Drug Alias Name人脐带来源3D间充质干细胞
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesSaipu Biotechnology (Changchun) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSaipu Biotechnology (Changchun) Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic Stroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A